Enliven Therapeutics Inc. Net Asset Quality Index

Latest as of June 2026: 98.3%

Enliven Therapeutics Inc. net asset quality index. Enliven Therapeutics Inc. (ELVN) has a Net Asset Quality Index of 98.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $910.22 Million minus total liabilities of $15.07 Million yields net assets of $895.15 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore debt repayment capacity of Enliven Therapeutics Inc. to assess how comfortably operating cash covers total debt obligations.

Quality Index

98.3%
Equity / Total Assets

Net Assets

$895.15 Million
USD

Total Assets

$910.22 Million
USD

Total Liabilities

$15.07 Million
USD

Net Asset Quality Index of Enliven Therapeutics Inc. (2017–2025)

Net asset quality index of Enliven Therapeutics Inc. from 2017 to 2025. This chart shows how Enliven Therapeutics Inc.'s Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 98.3%, representing net assets of $895.15 Million against total assets of $910.22 Million USD. See Enliven Therapeutics Inc. book value and equity for net asset value and shareholders' equity analysis.

Enliven Therapeutics Inc. Net Asset Quality Index by Year (2017–2025)

Enliven Therapeutics Inc. net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for Enliven Therapeutics Inc. from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ELVN stock market capitalisation.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2025 96.5% $459.49 Million $476.17 Million $16.68 Million ▲ +1.4 pp
2024 95.1% $309.85 Million $325.76 Million $15.91 Million ▲ +4.7 pp
2023 90.5% $245.91 Million $271.87 Million $25.96 Million ▲ +182.7 pp
2022 -92.2% $-76.83 Million $83.30 Million $160.12 Million ▼ -186.5 pp
2021 94.3% $106.86 Million $113.33 Million $6.47 Million ▲ +1.3 pp
2020 92.9% $84.44 Million $90.84 Million $6.41 Million ▲ +6.1 pp
2019 86.8% $28.92 Million $33.30 Million $4.38 Million ▲ +10.6 pp
2018 76.2% $5.87 Million $7.71 Million $1.83 Million ▼ -9.2 pp
2017 85.5% $8.74 Million $10.22 Million $1.49 Million —
pp = percentage points